Scott Akamine

This profile gathers the share dealings of Scott Akamine in Cerevel Therapeutics Holdings, Inc. Over a trading history stretching from 8 August 2022 to 1 August 2024, the count stands at 5 filings.

Every open-market trade on record is a sale: 1 sale worth €392k. Other entries cover 3 option exercises.

Most recently, on 5 August 2024, the filings show a transaction in Cerevel Therapeutics Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.